Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma

Oncology Today with Dr Neil Love: Bispecific ...

Up next

Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances

Dr Amir Fathi from Massachusetts General Hospital in Boston, Massachusetts, and Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discuss key clinical trial data surrounding the use of menin inhibitors in the management of AML.CME information an ...  Show more

CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson

Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.CME information and select publications here.